Literature DB >> 12930721

Molecular cloning of complementary DNA encoding mouse seminal vesicle-secreted protein SVS I and demonstration of homology with copper amine oxidases.

Ake Lundwall1, Johan Malm, Adam Clauss, Camilla Valtonen-Andre, A Yvonne Olsson.   

Abstract

The primary structure of mouse SVS I was determined by peptide sequencing and nucleotide sequencing of cloned cDNA. The precursor molecule consists of 820 amino acid residues, including a signal peptide of 24 residues, and the mature polypeptide chain of 91 kDa has one site for potential N-linked glycosylation. The SVS I is homologous with amiloride-binding protein 1 (ABP1), a diamine oxidase. However, it probably lacks enzymatic activity, because the cDNA codes for His instead of Tyr at the position of the active-site topaquinon. The SVS I monomer probably binds one molecule of copper, because the His residues coordinated by Cu(II) are conserved. The SVS I gene consists of five exons and is situated on mouse chromosome 6,B2.3. It is located in a region of 100 kilobases (kb) containing several genes with homology to SVS I, including the gene of ABP1 and two other proteins with homology to diamine oxidase. The locus is conserved on rat chromosome 4q24, but the homologous region on human chromosome 7q34-q36 solely contains ABP1. The other genes with homology to diamine oxidase were probably present in a progenitor of primates and rodents but were lost in the evolutionary lineage leading to humans-presumably during recombination between chromosomes. The estimated molecular mass of rat SVS I is 102 kDa (excluding glycosylation). The species difference in size of SVS I is caused by tandem repeats of 18 amino acid residues in the central part of the molecule: The mouse has seven repeats, and the rat has 12 repeats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930721     DOI: 10.1095/biolreprod.103.019984

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  7 in total

1.  Prostate-targeted mTOR-shRNA inhibit prostate cancer cell growth in human tumor xenografts.

Authors:  Yue-Feng Du; Qing-Zhi Long; Ying Shi; Xiao-Gang Liu; Xu-Dong Li; Jin Zeng; Yong-Guang Gong; Xin-Yang Wang; Da-Lin He
Journal:  Int J Clin Exp Med       Date:  2013-01-26

2.  Adaptive evolution in rodent seminal vesicle secretion proteins.

Authors:  Robert C Karn; Nathaniel L Clark; Eric D Nguyen; Willie J Swanson
Journal:  Mol Biol Evol       Date:  2008-08-20       Impact factor: 16.240

3.  Deletion of androgen receptor in the smooth muscle of the seminal vesicles impairs secretory function and alters its responsiveness to exogenous testosterone and estradiol.

Authors:  Michelle Welsh; Lindsey Moffat; Laura Jack; Alan McNeilly; David Brownstein; Philippa T K Saunders; Richard M Sharpe; Lee B Smith
Journal:  Endocrinology       Date:  2010-05-05       Impact factor: 4.736

4.  Comparative proteomic analysis of proteins involved in the tumorigenic process of seminal vesicle carcinoma in transgenic mice.

Authors:  Wei-Chao Chang; Chuan-Kai Chou; Chih-Chiang Tsou; Sheng-Hsiang Li; Chein-Hung Chen; Yu-Xing Zhuo; Wen-Lian Hsu; Chung-Hsuan Chen
Journal:  Int J Proteomics       Date:  2010-05-12

5.  Phylogenetic and chromosomal analyses of multiple gene families syntenic with vertebrate Hox clusters.

Authors:  Görel Sundström; Tomas A Larsson; Dan Larhammar
Journal:  BMC Evol Biol       Date:  2008-09-19       Impact factor: 3.260

6.  Glucagon-Like Peptide 1 Receptor Agonist Improves Renal Tubular Damage in Mice with Diabetic Kidney Disease.

Authors:  Ran Li; Dunmin She; Zhengqin Ye; Ping Fang; Guannan Zong; Yong Zhao; Kerong Hu; Liya Zhang; Sha Lei; Keqin Zhang; Ying Xue
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-29       Impact factor: 3.249

7.  Identification of the major rabbit and guinea pig semen coagulum proteins and description of the diversity of the REST gene locus in the mammalian clade Glires.

Authors:  Åke Lundwall; Margareta Persson; Karin Hansson; Magnus Jonsson
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.